Document is current
Any future updates will be listed below
-
Authors
Greenfield, Jerry R.
Frampton, Ruth
Millard, Kellie
Snaith, Jennifer R.
- License Information
-
More Information
Article History
Received: 6 November 2024
Accepted: 11 December 2024
First Online: 6 January 2025
Declarations
:
: Jerry Greenfield, Ruth Frampton and Jennifer Snaith have received semaglutide and placebo for a randomised placebo-controlled study in type 1 diabetes. Jerry Greenfield has received honorarium from the following companies for delivering talks to health professionals over the last 10 years: Novartis, Novo Nordisk, Amgen, Allergan, Boehringer Inglheim, Lilly and Abbott. Jennifer Snaith is supported by JDRF Australia.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
